Gulzhan Tologonova
Current Organizations / Institutes
The organizations/institutes from the scholar's latest article
Previous Organizations / Institutes
The organizations / institutes from the scholar's other articles in the past ten years
Research Subjects
Research Interests
Gulzhan Tologonova has a total of 27 co-authors. Here are the top co-authors by number of shared publications:
- Jason M. Lazar
Division of Cardiovascular Medicine, State University of New York Downstate Health Sciences University, Brooklyn, USA
2 shared publications - Jeffrey P. Weiss
Department of Urology, SUNY Downstate Health Sciences University, Brooklyn, USA
2 shared publications - Anthony Brooks1 shared publication
Elka Jacobson-Dickman
1 shared publicationJason M. Lazar
1 shared publication- Karel Everaert
Department of Urology, Ghent University Hospital, Ghent, Belgium
1 shared publication
Latest Publications
- Open Access
- 22 October 2026
- Published by MDPI AG in Clocks & Sleep
- Vol. 8 (4) , 69
Which Blood Pressure Measures Correlate with Nocturia Severity in Adolescents?
Nocturia, defined as waking to void during sleep hours, is common in adolescents, causing sleep disruption and daytime fatigue. While numerous studies have found nocturia associated with systolic blood pressure (BP) hypertension in adults, diastolic (D) BP has greater relative importance in youth. Little is known about the hemodynamic profile of the hypertension–nocturia link in adolescents. Accordingly, we evaluated relationships between nocturia severity and brachial artery systolic and DBPs in each arm, as well as central aortic pressures using applanation tonometry. We studied 100 adolescents, 10–18 years, from pediatric clinics. Nocturnal urinary indices were obtained from voiding diaries. Results: In total, 45% reported nocturia. Nocturia severity was correlated with left and right arm brachial SBP, higher of two arms, and central SBP (r = 0.27, p = 0.007). Brachial SBP was also correlated with nocturnal urine volume (NUV) (r = 0.31, p = 0.001) and production rate (NUP) (r = 0.32, p = 0.001). DBP showed no significant correlations. After adjusting for BMI and sex, brachial SBP remained independently associated with nocturia severity. The median first uninterrupted sleep period was 171 min (25–75%ile; 94, 300). In adolescents, SBP is associated with nocturia severity, NUV, and NUP. Nocturia typically occurs during the first half of nighttime, suggesting an impact on deep sleep.
- 22 October 2026
- Published by MDPI AG in Clocks & Sleep
- Vol. 8 (4) , 69
Open AccessWhich Blood Pressure Measures Correlate with Nocturia Severity in Adolescents?
Nocturia, defined as waking to void during sleep hours, is common in adolescents, causing sleep disruption and daytime fatigue. While numerous studies have found nocturia associated with systolic blood pressure (BP) hypertension in adults, diastolic (D) BP has greater relative importance in youth. Little is known about the hemodynamic profile of the hypertension–nocturia link in adolescents. Accordingly, we evaluated relationships between nocturia severity and brachial artery systolic and DBPs in each arm, as well as central aortic pressures using applanation tonometry. We studied 100 adolescents, 10–18 years, from pediatric clinics. Nocturnal urinary indices were obtained from voiding diaries. Results: In total, 45% reported nocturia. Nocturia severity was correlated with left and right arm brachial SBP, higher of two arms, and central SBP (r = 0.27, p = 0.007). Brachial SBP was also correlated with nocturnal urine volume (NUV) (r = 0.31, p = 0.001) and production rate (NUP) (r = 0.32, p = 0.001). DBP showed no significant correlations. After adjusting for BMI and sex, brachial SBP remained independently associated with nocturia severity. The median first uninterrupted sleep period was 171 min (25–75%ile; 94, 300). In adolescents, SBP is associated with nocturia severity, NUV, and NUP. Nocturia typically occurs during the first half of nighttime, suggesting an impact on deep sleep.
- Open Access
- 23 January 2025
- Published by Elsevier in Continence
- Vol. 13
Defining Nocturnal Polyuria in Adolescents
- 23 January 2025
- Published by Elsevier in Continence
- Vol. 13
Open AccessDefining Nocturnal Polyuria in Adolescents
- Open Access
- 28 September 2022
- Published by JMIR Publications Inc. in JMIR Formative Research
- Vol. 6 (9) , e41241
Comparison Between QT and Corrected QT Interval Assessment by an Apple Watch With the AccurBeat Platform and by a 12‑Lead Electrocardiogram With Manual Annotation: Prospective Observational Study
Background: Abnormal prolongation or shortening of the QT interval is associated with increased risk for ventricular arrhythmias and sudden cardiac death. For continuous monitoring, widespread use, and prevention of cardiac events, advanced wearable technologies are emerging as promising surrogates for conventional 12‑lead electrocardiogram (ECG) QT interval assessment. Previous studies have shown a good agreement between QT and corrected QT (QTc) intervals measured on a smartwatch ECG and a 12-lead ECG, but the clinical accuracy of computerized algorithms for QT and QTc interval measurement from smartwatch ECGs is unclear. Objective: The prospective observational study compared the smartwatch-recorded QT and QTc assessed using AccurKardia’s AccurBeat platform with the conventional 12‑lead ECG annotated manually by a cardiologist. Methods: ECGs were collected from healthy participants (without any known cardiovascular disease) aged >22 years. Two consecutive 30-second ECG readings followed by (within 15 minutes) a 10-second standard 12-lead ECG were recorded for each participant. Characteristics of the participants were compared by sex using a 2-sample t test and Wilcoxon rank sum test. Statistical comparisons of heart rate (HR), QT interval, and QTc interval between the platform and the 12-lead ECG, ECG lead I, and ECG lead II were done using the Wilcoxon sign rank test. Linear regression was used to predict QTc and QT intervals from the ECG based on the platform’s QTc/QT intervals with adjustment for age, sex, and difference in HR measurement. The Bland-Altman method was used to check agreement between various QT and QTc interval measurements. Results: A total of 50 participants (32 female, mean age 46 years, SD 1 year) were included in the study. The result of the regression model using the platform measurements to predict the 12-lead ECG measurements indicated that, in univariate analysis, QT/QTc intervals from the platform significantly predicted QT/QTc intervals from the 12-lead ECG, ECG lead I, and ECG lead II, and this remained significant after adjustment for sex, age, and change in HR. The Bland-Altman plot results found that 96% of the average QTc interval measurements between the platform and QTc intervals from the 12-lead ECG were within the 95% confidence limit of the average difference between the two measurements, with a mean difference of –10.5 (95% limits of agreement –71.43, 50.43). A total of 94% of the average QT interval measurements between the platform and the 12-lead ECG were within the 95% CI of the average difference between the two measurements, with a mean difference of –6.3 (95% limits of agreement –54.54, 41.94). Conclusions: QT and QTc intervals obtained by a smartwatch coupled with the platform’s assessment were comparable to those from a 12-lead ECG. Accordingly, with further refinements, remote monitoring using this technology holds promise for the identification of QT interval prolongation.
- 28 September 2022
- Published by JMIR Publications Inc. in JMIR Formative Research
- Vol. 6 (9) , e41241
Open AccessComparison Between QT and Corrected QT Interval Assessment by an Apple Watch With the AccurBeat Platform and by a 12‑Lead Electrocardiogram With Manual Annotation: Prospective Observational Study
Background: Abnormal prolongation or shortening of the QT interval is associated with increased risk for ventricular arrhythmias and sudden cardiac death. For continuous monitoring, widespread use, and prevention of cardiac events, advanced wearable technologies are emerging as promising surrogates for conventional 12‑lead electrocardiogram (ECG) QT interval assessment. Previous studies have shown a good agreement between QT and corrected QT (QTc) intervals measured on a smartwatch ECG and a 12-lead ECG, but the clinical accuracy of computerized algorithms for QT and QTc interval measurement from smartwatch ECGs is unclear. Objective: The prospective observational study compared the smartwatch-recorded QT and QTc assessed using AccurKardia’s AccurBeat platform with the conventional 12‑lead ECG annotated manually by a cardiologist. Methods: ECGs were collected from healthy participants (without any known cardiovascular disease) aged >22 years. Two consecutive 30-second ECG readings followed by (within 15 minutes) a 10-second standard 12-lead ECG were recorded for each participant. Characteristics of the participants were compared by sex using a 2-sample t test and Wilcoxon rank sum test. Statistical comparisons of heart rate (HR), QT interval, and QTc interval between the platform and the 12-lead ECG, ECG lead I, and ECG lead II were done using the Wilcoxon sign rank test. Linear regression was used to predict QTc and QT intervals from the ECG based on the platform’s QTc/QT intervals with adjustment for age, sex, and difference in HR measurement. The Bland-Altman method was used to check agreement between various QT and QTc interval measurements. Results: A total of 50 participants (32 female, mean age 46 years, SD 1 year) were included in the study. The result of the regression model using the platform measurements to predict the 12-lead ECG measurements indicated that, in univariate analysis, QT/QTc intervals from the platform significantly predicted QT/QTc intervals from the 12-lead ECG, ECG lead I, and ECG lead II, and this remained significant after adjustment for sex, age, and change in HR. The Bland-Altman plot results found that 96% of the average QTc interval measurements between the platform and QTc intervals from the 12-lead ECG were within the 95% confidence limit of the average difference between the two measurements, with a mean difference of –10.5 (95% limits of agreement –71.43, 50.43). A total of 94% of the average QT interval measurements between the platform and the 12-lead ECG were within the 95% CI of the average difference between the two measurements, with a mean difference of –6.3 (95% limits of agreement –54.54, 41.94). Conclusions: QT and QTc intervals obtained by a smartwatch coupled with the platform’s assessment were comparable to those from a 12-lead ECG. Accordingly, with further refinements, remote monitoring using this technology holds promise for the identification of QT interval prolongation.